Blog: Nestle receives green light on Pfizer deal
Michelle Russell | 6 November 2012
Swiss food group Nestle today (6 November) received approval from the Chinese Ministry of Commerce for its US$11.85bn deal to acquire Pfizer's infant nutrition business.
The approval brings Nestle another step closer to completing the acquisition, which was announced in April this year, enabling the world's largest infant nutrition group to extend its lead in this fast-growing category.
Pfizer Nutrition operates in more than 60 countries globally and 85% of sales are generated in emerging markets, meaning the acquisition effectively fills in the blanks on the map for Nestle. It will provide the company with increased scale in a high-growth, high-margin, category in fast-growing developing markets, CEO Paul Bulcke told investors as it emerged as victor of competitive auction process.
Nestle beat companies including Danone and Mead Johnson to seal the agreement. The next hurdle, however, is to receive approval from anti-trust bodies in several countries in order to fully complete the acquisition.
Fyffes, the global produce supplier, is in the spotlight over union claims of worker abuse on plantations in Central America....
Mark Price, the outgoing managing director of UK grocer Waitrose, has been named the country's new trade minister....
Last autumn, a US trade group said it would look to develop a voluntary regulatory compliance and certification programme for the term 'natural', with an eye on releasing the standard in the first hal...
- just-food's pick: Innovation on show at ISM 2016
- What are the implications of Brexit for UK food?
- Mondelez results and outlook - 7 things to learn
- Richelieu Foods CEO eyes growth - interview
- Foodservice focus: McDonald's/Five Guys/Starbucks
- Mars to cut artificial colours from global foods
- Chobani targets growth after rejecting offers
- PepsiCo's Nooyi: "macro challenges" will continue
- Private-equity firm HKW acquires Panos Brands
- WWF launches food security platform